0001104659-22-122151.txt : 20221125
0001104659-22-122151.hdr.sgml : 20221125
20221125181350
ACCESSION NUMBER: 0001104659-22-122151
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221123
FILED AS OF DATE: 20221125
DATE AS OF CHANGE: 20221125
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dye Justin
CENTRAL INDEX KEY: 0001654539
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-55450
FILM NUMBER: 221420917
MAIL ADDRESS:
STREET 1: C/O MEDICINE MAN TECHNOLOGIES, INC.
STREET 2: 4880 HAVANA STREET, SUITE 201
CITY: DENVER
STATE: CO
ZIP: 80239
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Medicine Man Technologies, Inc.
CENTRAL INDEX KEY: 0001622879
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MANAGEMENT CONSULTING SERVICES [8742]
IRS NUMBER: 465289499
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4880 HAVANA STREET
STREET 2: SUITE 201 SOUTH
CITY: DENVER
STATE: CO
ZIP: 80239
BUSINESS PHONE: 303-371-0387
MAIL ADDRESS:
STREET 1: 4880 HAVANA STREET
STREET 2: SUITE 201 SOUTH
CITY: DENVER
STATE: CO
ZIP: 80239
4
1
tm2230784-3_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2022-11-23
0
0001622879
Medicine Man Technologies, Inc.
SHWZ
0001654539
Dye Justin
C/O MEDICINE MAN TECHNOLOGIES, INC.
4880 HAVANA ST., STE. 201
DENVER
CO
80239
1
1
1
0
CEO
Common Stock
2022-11-23
4
A
0
509700
2.00
A
1368062
D
Common Stock
9287500
I
See footnote
The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $1.79 to $2.10 per share. The Reporting Person undertakes to provide to the
Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this
footnote.
Represents shares of common stock held by Dye Capital & Company, LLC ("Dye Capital"). As the general partner of Dye Capital, Mr. Dye has voting and investment control over the securities held by Dye Capital. Mr. Dye disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein.
/s/ Daniel R. Pabon, Attorney-in-Fact for Justin Dye
2022-11-25